Seigo Terawaki
Kurashiki, 7010192, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 26 publications
M6PR/IGF2R double-knockout supplies therapeutic sources for mucolipidosis II and Niemann-Pick C2.
Journal: The Journal of biological chemistry
Published: July 16, 2026
Cellular Lyso-Gb3 Is a Biomarker for Mucolipidosis II.
Journal: International journal of molecular sciences
Published: June 08, 2025
Triclabendazole suppresses cellular levels of glycosaminoglycan-A potential therapeutic agent for mucopolysaccharidoses and related diseases.
Journal: iScience
Published: December 02, 2024
Impaired lysosomal acidity maintenance in acid lipase-deficient cells leads to defective autophagy.
Journal: The Journal of biological chemistry
Published: October 30, 2023
A case series of Fabry diseases with CKD in Japan.
Journal: Clinical and experimental nephrology
Published: September 19, 2023
HOPS, CORVET and newly-identified Hybrid tethering complexes contribute differentially towards multiple modes of endocytosis.
Journal: Scientific reports
Published: August 18, 2023
Prenatal Diagnosis of Mucopolysaccharidosis-Plus Syndrome (MPSPS).
Journal: Genes
Published: July 04, 2023
A Case of Mucopolysaccharidosis II Caused by a Novel Variant with Skin Linear Hyperpigmented Streaks along Blaschko's Lines.
Journal: International journal of molecular sciences
Published: February 14, 2023
Involvement of heterologous ubiquitination including linear ubiquitination in Alzheimer's disease and amyotrophic lateral sclerosis.
Journal: Frontiers in molecular biosciences
Published: November 04, 2022
Suppression of Linear Ubiquitination Ameliorates Cytoplasmic Aggregation of Truncated TDP-43.
Journal: Cells
Published: June 22, 2022
Hematopoietic Disorders, Renal Impairment and Growth in Mucopolysaccharidosis-Plus Syndrome.
Journal: International journal of molecular sciences
Published: May 02, 2022
Last Updated: 09/26/2026